tirzepatide semaglutide blend Compounded GLP-1 - & Compound Tirzepatide
Description
As a result, drowsiness is not a commonly reported side effect with intranasal use, unlike oral antihistamines
99% purity, HPLC-tested, COA
Dawka pocztkowa: 50 jednostek (2,5 mg)
Prescribed if clinically appropriate
